Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
UBS
Covington
Teva
McKinsey
Harvard Business School
Deloitte
Accenture
Federal Trade Commission

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062237

« Back to Dashboard

NDA 062237 describes ERYTHROMYCIN ESTOLATE, which is a drug marketed by Barr, Ivax Sub Teva Pharms, Watson Labs, Alpharma Us Pharms, G And W Labs Inc, and Life Labs, and is included in seven NDAs. Additional details are available on the ERYTHROMYCIN ESTOLATE profile page.

The generic ingredient in ERYTHROMYCIN ESTOLATE is erythromycin estolate. There are one hundred and two drug master file entries for this compound. Additional details are available on the erythromycin estolate profile page.
Summary for 062237
Tradename:ERYTHROMYCIN ESTOLATE
Applicant:Ivax Sub Teva Pharms
Ingredient:erythromycin estolate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 250MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Merck
Chinese Patent Office
Boehringer Ingelheim
McKesson
Moodys
Covington
Citi
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.